Palo Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTX
BC
ACA
AC
BFA
AC
ECP
TC
BIT
ACP
Palo Capital's PTX Position: Q3 2015 in Review
Palo Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2015, closing a stake of 1,020 shares — an estimated $60K sold.
Palo Capital first reported a position in PTX in Q2 2015 and held it in 1 quarter. The position peaked at $60K in Q2 2015. 104 funds tracked by Wall St. Rank hold PTX as of Q3 2015.
- Palo Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
- Palo Capital sold 1,020 Pernix Therapeutics Holdings, Inc. shares in Q3 2015, an estimated $60K.
- Palo Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 1 quarter.
- Palo Capital's Pernix Therapeutics Holdings, Inc. position peaked at $60K in Q2 2015.
- 104 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2015.
Based on Palo Capital's 13F filing for Q3 2015, filed 12 Nov 2015.